Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 119

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 8
Chunk 119
---
 $539,359 $505,855 Infusion Systems167,696 163,638 333,996 320,976 Vital Care108,037 171,001 280,213 336,279 Total Revenues$548,866 $596,455 $1,153,568 $1,163,110 The following table represents our revenues disaggregated by geography (in thousands):Three months ended June 30,Six months ended June 30,Geography2025202420252024United States$335,432 $383,140 $723,676 $749,295 Europe, the Middle East and Africa99,059 95,310 194,747 193,699 APAC58,404 61,224 117,816 113,077 Other Foreign55,971 56,781 117,329 107,039 Total Revenues$548,866 $596,455 $1,153,568 $1,163,110     Contract Balances    The following table presents the changes in our contract balances for the six months ended June 30, 2025 and 2024 (in thousands), which is included in accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets:

14

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

Contract LiabilitiesBeginning balance, January 1, 2025$39,403 Equipment revenue recognized(33,525)Equipment revenue deferred due to implementation30,365 Software revenue recognized(6,348)Software revenue deferred due to implementation2,473 Government grant income recognized(1) (1,024)Other deferred revenue recognized(1,156)Other deferred revenue 390 Ending balance, June 30, 2025$30,578 Beginning balance, January 1, 2024$42,177 Equipment revenue recognized(16,951)Equipment revenue deferred due to implementation20,593 Software revenue recognized(10,232)Software revenue deferred due to implementation10,427 Government grant income recognized(1) (1,029)Other deferred revenue recognized(1,602)Other deferred revenue423 Ending balance, June 30, 2024$43,806 ____________________________(1) The government grant income deferred is amortized over the life